Pancrelipase Market Size Expands with Increasing Long-Term Therapy Adoption
The Pancrelipase Market continues to expand in size as long-term enzyme replacement therapy becomes increasingly essential for patients with pancreatic enzyme insufficiency. This condition, often linked to chronic pancreatitis, cystic fibrosis, pancreatic cancer, and post-surgical complications, requires consistent and lifelong management. As awareness grows among healthcare providers and...
0 Comments 0 Shares 169 Views